{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:54:28Z","timestamp":1791078868105,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.dld.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T09:20:09Z","timestamp":1531905609000},"page":"894-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) \u2014 Study section \u201cDigestive Diseases in Primary Care\u201d"],"prefix":"10.1016","volume":"50","author":[{"given":"Vincenzo","family":"Savarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Tosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Compare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (4)","key":"10.1016\/j.dld.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2018.07.004_bib0015","unstructured":"OECD.Stat. http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=HEALTH_PHMC. [Accessed on 17 May 2018]."},{"key":"10.1016\/j.dld.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1756283X12437358","article-title":"Overutilization of proton-pump inhibitors: what the clinician needs to know","volume":"5","author":"Heidelbaugh","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"issue":"12","key":"10.1016\/j.dld.2018.07.004_bib0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.dld.2016.05.018","article-title":"Are proton pump inhibitors really so dangerous","volume":"48","author":"Savarino","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00228-010-0871-9","article-title":"Appropriateness of treatment recommendations for PPI in hospital discharge letters","volume":"66","author":"Ahrens","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dld.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1046\/j.1365-2036.2003.01600.x","article-title":"Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey","volume":"17","author":"Parente","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0045","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1097\/MCG.0b013e3182151be7","article-title":"A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study","volume":"45","author":"Morini","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MAJ.0b013e31829f87d5","article-title":"Potential costs of inappropriate use of proton pump inhibitors","volume":"347","author":"Ladd","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.dld.2018.07.004_bib0055","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2169\/internalmedicine.49.4064","article-title":"Patterns and predictors of proton pump inhibitor overuse among academic and nonacademic hospitalists","volume":"49","author":"Eid","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"92","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2018.07.004_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2036.2011.04742.x","article-title":"Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease","volume":"34","author":"Savarino","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1046\/j.1365-2036.2002.01248.x","article-title":"Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression","volume":"16","author":"Frazzoni","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.dld.2018.07.004_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000076371","article-title":"Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease","volume":"69","author":"Savarino","year":"2004","journal-title":"Digestion"},{"key":"10.1016\/j.dld.2018.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.phrs.2008.09.016","article-title":"Proton pump inhibitor in GORD: an overview of their pharmacology, efficacy and safety","volume":"59","author":"Savarino","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dld.2018.07.004_bib0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrgastro.2013.50","article-title":"NERD: an umbrella term including heterogeneous subpopulations","volume":"10","author":"Savarino","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0095","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/j.1572-0241.2008.02119.x","article-title":"The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy","volume":"103","author":"Savarino","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.dld.2004.03.019","article-title":"Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review","volume":"36","author":"Zentilin","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0105","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrgastro.2017.130","article-title":"Expert consensus document: advances in the physiological assessment and diagnosis of GERD","volume":"14","author":"Savarino","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0110","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/ajg.2009.670","article-title":"Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and non-erosive reflux disease: study using combined impedance-pH off therapy","volume":"105","author":"Savarino","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2018.07.004_bib0115","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-esophageal reflux disease-like symptoms and endoscopy-negative reflux disease","author":"van Pinxteren","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0120","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Functional esophageal disorders","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","article-title":"Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group","volume":"10","author":"Carlsson","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199510263331703","article-title":"A comparison of five maintenance therapies for reflux esophagitis","volume":"333","author":"Vigneri","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ijcp.12623","article-title":"Management of reflux esophagitis: does the choice of proton pump inhibitor matter?","volume":"69","author":"Labenz","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dld.2018.07.004_bib0140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bpg.2013.06.009","article-title":"Approach to the patient with presumed extraoesophageal GERD","volume":"27","author":"Ates","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1378\/chest.12-1788","article-title":"Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease","volume":"143","author":"Kahrilas","year":"2013","journal-title":"Chest"},{"issue":"February (4)","key":"10.1016\/j.dld.2018.07.004_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2006.03213.x","article-title":"Meta-analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro-oesophageal reflux disease","volume":"25","author":"Gatta","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000171190","article-title":"Pharmacological bases of the medical treatment of gastroesophageal reflux disease","volume":"6","author":"Scarpignato","year":"1988","journal-title":"Dig Dis"},{"issue":"2","key":"10.1016\/j.dld.2018.07.004_bib0160","article-title":"Gastro-oesophageal reflux treatment for asthma in adults and children","author":"Gibson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0165","first-page":"269","article-title":"Extraesophageal manifestations in gastroesophageal reflux disease","volume":"52","author":"Jaspersen","year":"2006","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.dld.2018.07.004_bib0170","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.3748\/wjg.v18.i32.4363","article-title":"How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related","volume":"18","author":"de Bortoli","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0175","first-page":"221","article-title":"Extra-esophageal presentation of gastroesophageal reflux disease: new understanding in a new era","volume":"63","author":"Martinucci","year":"2017","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.dld.2018.07.004_bib0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","article-title":"Effective and safe proton pump inhibitor therapy in acid-related diseases \u2014 a position paper addressing benefits and potential harms of acid suppression","volume":"14","author":"Scarpignato","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0016-5107(96)70055-X","article-title":"Partial regression of Barrett\u2019s esophagus by long-term therapy \u2019with high-dose omeprazole","volume":"44","author":"Malesci","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.dld.2018.07.004_bib0190","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett\u2019s oesophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.dld.2018.07.004_bib0200","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cgh.2012.11.014","article-title":"Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett\u2019s esophagus","volume":"11","author":"Kastelein","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.dld.2013.02.015","article-title":"Eosinophilic oesophagitis: from physiopathology to treatment","volume":"45","author":"Roman","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0210","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13104","article-title":"Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group","volume":"29","author":"Gyawali","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.dld.2018.07.004_bib0215","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/gutjnl-2015-310991","article-title":"Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis","volume":"65","author":"Molina-Infante","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.07.004_bib0220","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/apt.13718","article-title":"The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon","volume":"44","author":"Savarino","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0225","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","article-title":"Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications","volume":"54","author":"Kedika","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2018.07.004_bib0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.dld.2016.11.012","article-title":"Eosinophilic esophagitis: update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE)","volume":"49","author":"de Bortoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0235","first-page":"62","article-title":"Eosinophilic esophagitis: current evidence-based diagnosis and treatment in children and adults","volume":"64","author":"Lucendo","year":"2018","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.dld.2018.07.004_bib0240","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2015.06.010","article-title":"Guidelines for the management of Helicobacter pylori infection in Italy: the III Working Group Consensus Report 2015","volume":"47","author":"Zagari","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0245","first-page":"4","article-title":"Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection","volume":"31","author":"Savarino","year":"1999","journal-title":"Ital J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0250","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-116-9-705","article-title":"Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study","volume":"116","author":"Graham","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0255","article-title":"Sequential versus standard triple first-line therapy for Helicobacter pylori eradication","volume":"6","author":"Nyssen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0260","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients","volume":"2","author":"Ford","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0265","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0270","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1365-2036.1998.00416.x","article-title":"Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer","volume":"12","author":"Savarino","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1365-2036.2009.04105.x","article-title":"Review article: Helicobacter pylori-negative duodenal ulcer disease","volume":"30","author":"Gisbert","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 2","key":"10.1016\/j.dld.2018.07.004_bib0280","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2036.2001.00114.x","article-title":"Review article: role of proton pump inhibitors in non-H. pylori-related ulcers","volume":"15","author":"Freston","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0285","first-page":"1409","article-title":"Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis\u2014results from a randomized trial with 2-year follow-up","volume":"96","author":"Bytzer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0290","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2036.1997.146322000.x","article-title":"Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output","volume":"11","author":"Harris","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0295","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/bega.2001.0187","article-title":"Current indications for acid suppressants in Helicobacter pylori-negative ulcer disease","volume":"15","author":"Howden","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0300","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","article-title":"Control of gastric acid secretion in health and disease","volume":"134","author":"Schubert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0305","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/A:1018834301901","article-title":"Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients","volume":"43","author":"Savarino","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2018.07.004_bib0310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-230X-2-17","article-title":"Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials","volume":"2","author":"Salas","year":"2002","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0315","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/gast.2002.36013","article-title":"Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis","volume":"123","author":"Laine","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.07.004_bib0325","first-page":"160","article-title":"The appropriate use of proton pump inhibitors (PPIs): need for a reappraisal","volume":"45","author":"Savarino","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/11589340-000000000-00000","article-title":"Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients","volume":"28","author":"de Abajo","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.dld.2018.07.004_bib0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2474-7-79","article-title":"Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice","volume":"7","author":"Moore","year":"2006","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.dld.2018.07.004_bib0340","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.dld.2018.07.004_bib0345","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ijcp.12634","article-title":"Should patients prescribed long-term low-dose aspirin receive proton pump inhibitors? A systematic review and meta-analysis","volume":"69","author":"Tran-Duy","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.dld.2018.07.004_bib0350","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002094.pub3","article-title":"Proton pump inhibitor treatment for acute peptic ulcer bleeding","author":"Leontiadis","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0355","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.3748\/wjg.v21.i20.6341","article-title":"Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: a meta-analysis","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0360","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3109\/00365529709007691","article-title":"Does profound acid inhibition improve haemostasis in peptic ulcer bleeding","volume":"32","author":"Berstad","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0365","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gut.30.12.1704","article-title":"Clot lysis by gastric juice: an in vitro study","volume":"30","author":"Patchett","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.07.004_bib0370","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2011.480","article-title":"Management of patients with ulcer bleeding","volume":"107","author":"Laine","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0375","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2014.4056","article-title":"Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis","volume":"174","author":"Sachar","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0380","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-150-7-200904070-00105","article-title":"Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial","volume":"150","author":"Sung","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0385","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12441","article-title":"Meta-analysis: comparison of oral vs. intravenous proton pump inhibitors in patients with peptic ulcer bleeding","volume":"38","author":"Tsoi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2005.02546.x","article-title":"Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay\u2014results from the Cochrane Collaboration","volume":"22","author":"Leontiadis","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0395","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrgastro.2014.235","article-title":"Stress-related mucosal disease in the critically ill patient","volume":"12","author":"Bardou","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0400","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/CCM.0b013e3182758734","article-title":"Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ajg.2011.474","article-title":"Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis","volume":"107","author":"Barkun","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0410","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/TCRM.S81759","article-title":"Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review","volume":"11","author":"Shin","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.dld.2018.07.004_bib0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic)","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2018.07.004_bib0420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dld.2018.07.004_bib0425","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1517\/14656560902887035","article-title":"Treatment strategies for Zollinge-Ellison syndrome","volume":"10","author":"Wilcox","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.dld.2018.07.004_bib0430","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00365521.2012.746395","article-title":"Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment","volume":"48","author":"L\u00f8drup","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0435","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0440","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.39.4.508","article-title":"Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum","volume":"39","author":"Savarino","year":"1996","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.dld.2018.07.004_bib0445","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001960.pub3","article-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2018.07.004_bib0450","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","article-title":"Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials","volume":"5","author":"Wang","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0455","unstructured":"National Institute for Health and Care Excellence. Management of dyspepsia in adults in primary care. August 2004, revised July 2005."},{"key":"10.1016\/j.dld.2018.07.004_bib0460","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000103879","article-title":"Functional heartburn and non-erosive reflux disease","volume":"25","author":"Savarino","year":"2007","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2018.07.004_bib0465","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gut.2008.175810","article-title":"Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease","volume":"58","author":"Savarino","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.07.004_bib0470","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.3748\/wjg.v19.i35.5787","article-title":"Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome","volume":"19","author":"de Bortoli","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0475","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/ajg.2016.432","article-title":"Functional heartburn overlaps with irritable bowel syndrome more often than GERD","volume":"111","author":"de Bortoli","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.07.004_bib0480","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gutjnl-2011-300798","article-title":"Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease","volume":"61","author":"Zerbib","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2018.07.004_bib0485","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0490","first-page":"619","article-title":"Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy","volume":"236","author":"Conn","year":"1994","journal-title":"J Inten Med"},{"key":"10.1016\/j.dld.2018.07.004_bib0495","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1053\/j.gastro.2016.08.054","article-title":"Association of proton pump inhibitors with reduced risk of warfarin-related serious upper gastrointestinal bleeding","volume":"151","author":"Ray","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0500","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2141.2011.08633.x","article-title":"Proton pump inhibitors and the risk of overcoagulation during acenocoumarol maintenance treatment","volume":"153","author":"Teichert","year":"2011","journal-title":"Br J Hematol"},{"key":"10.1016\/j.dld.2018.07.004_bib0505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/j.gastro.2011.03.049","article-title":"Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy","volume":"141","author":"Lin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.07.004_bib0510","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/j.1755-5922.2011.00289.x","article-title":"A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel","volume":"30","author":"Chen","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0515","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/eurheartj\/eht042","article-title":"Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy","volume":"34","author":"Agewall","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dld.2018.07.004_bib0520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2036.2007.03541.x","article-title":"Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs","volume":"27","author":"Loke","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.07.004_bib0525","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0168-8278(96)80067-5","article-title":"Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis","volume":"25","author":"Savarino","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.07.004_bib0530","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jgh.12065","article-title":"Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis","volume":"28","author":"Deshpande","year":"2013","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818308156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818308156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T19:32:25Z","timestamp":1571599945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818308156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":106,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1590865818308156"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.07.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appropriateness in prescribing PPIs: A position paper of the Italian Society of Gastroenterology (SIGE) \u2014 Study section \u201cDigestive Diseases in Primary Care\u201d","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}